Alpharma, Inc. (ALO)

forensicstockdoc (< 20) Submitted: 8/12/08 9:50 PM : Start Price: $24.66 ALO Score: 80.83

antiabuse formulations are the next catch to increase safety and ALO has it in the pipeline, Jason Napodano, sr. drug analyst at ZACKs picked this to go down last December and it did the opposite.


I saw it climb $10 a share. I hope Jason gets a clue. I am a doctor and I know what I want. When does Zacks stop paying Sr. Drug analyst to get it wrong??

Report this Post Replies: 0 | Reply | Permalink